Generali Investments Towarzystwo Funduszy Inwestycyjnych Dexcom Inc Transaction History
Generali Investments Towarzystwo Funduszy Inwestycyjnych
- $157 Billion
- Q1 2025
A detailed history of Generali Investments Towarzystwo Funduszy Inwestycyjnych transactions in Dexcom Inc stock. As of the latest transaction made, Generali Investments Towarzystwo Funduszy Inwestycyjnych holds 1,100 shares of DXCM stock, worth $88,297. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,100
Previous 1,100
-0.0%
Holding current value
$88,297
Previous $85.5 Million
12.19%
% of portfolio
0.05%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding DXCM
# of Institutions
1,080Shares Held
363MCall Options Held
8.41MPut Options Held
5.75M-
Vanguard Group Inc Valley Forge, PA47.5MShares$3.81 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.77 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.34 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.4MShares$1.15 Billion0.24% of portfolio
-
Baillie Gifford & CO14.2MShares$1.14 Billion0.87% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $31B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...